Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

ck4829

(37,682 posts)
Fri Mar 27, 2026, 07:17 AM 1 hr ago

Too bad our country prioritized the feelz of people who want witch trials back instead: Stem cells for heart failure

Medical breakthrough: Japan greenlights first-ever innovative stem cell therapy for severe heart failure

Japan's Ministry of Health, Labour and Welfare (MHLW) has become the first in the world to grant approval to the world's first innovative stem cell therapy for severe heart failure. The permission is conditional and based on a specific time duration for targeted regenerative medicine products for both severe heart failure and Parkinson's disease. Regenerative medicinal products focus on re-engineering parts of human or animal cells to restore the normal function of body tissues. The world's first pluripotent stem cell (iPSC)-based medicinal product, named ReHeart, has been developed by a company specializing in the creation of innovative medicinal products. This milestone is a major win for the global and Indian markets, as it is the first time that iPSC technology has been turned into commercial therapeutic products that were discovered in 2006.

Globally, heart disease affects 233 million people, out of which 19.41 million deaths were recorded, as per a recent joint report by the American Heart Association and Stroke Statistics Update. While in India, the number of cardiovascular diseases is 905 per 100,000 population (2021), and the deaths were at 2,873,266 as per the World Heart Federation. Not only are these figures alarming, but the need for global regenerative medicine could significantly minimise this global disease burden.

Japan's medical breakthrough is a sign that it is becoming a leader in the regenerative medicine field. Larger trials with varied data pools are needed for accurate assessment of effectiveness and long-term safety data.

https://www.msn.com/en-in/health/health-news/medical-breakthrough-japan-greenlights-first-ever-innovative-stem-cell-therapy-for-severe-heart-failure/ar-AA1YNhJx
Latest Discussions»Issue Forums»Single Payer Health Systems»Too bad our country prior...